Unconventional Interactions of Human Ubiquitin Conjugating Enzymes

人类泛素结合酶的非常规相互作用

基本信息

  • 批准号:
    8716782
  • 负责人:
  • 金额:
    $ 28.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-10 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

Intracellular communication via ubiquitin (Ub) signaling impacts all aspects of eukaryotic cell biology and regulates pathways critical to human development and viability. Aberrations or defects in Ub-signaling can result in numerous debilitating diseases including neurodegenerative diseases, infections, and cancer. Despite remarkable progress over the decades, we still have only a rudimentary understanding of the molecular factors and networks of interactions that govern the assembly of the proteins required for regulated Ub transfer and signaling. The ability to intervene in diseases related to Ub-signaling requires a thorough understanding of these pathways at the molecular level. The basic scheme for Ub modification involves the concerted activities and interactions of several different proteins. This proposal focuses on expanding our understanding of a central player in Ub-transfer reactions, the class of enzymes known as Ub-Conjugating Enzymes or E2s. Once thought simply to shuttle Ub to the site of modification, emerging evidence suggests that E2s can play a pivotal role in substrate recognition, determining the nature of Ub modification of a target protein, and even interacting with and influencing the activities of proteins outside the traditional Ub-transfer pathway. There are ~40 E2s in the human genome and most are thought to be directly involved in Ub transfer. Very little functional information is available for the majority of these E2s. The Research Plan outlined in this proposal seeks to substantially expand our understanding of E2 function. Using various biochemical approaches, NMR spectroscopy, crystallography, and mass spectrometry, this project seeks to develop a molecular understanding of the factors that govern 1) the intrinsic activity of E2~Ub conjugates toward particular residues, 2) E2~Ub recognition of substrates, and 3) and regulatory interactions of E2~Ub conjugates that regulate proteins outside the main Ub-transfer pathway. We have adapted and developed new tools with which to identify proteins selectively modified by particular E2~Ub conjugates. We make use of a new "in coli" expression system that can reconstruct Ub-transfer pathways in E. coli. This system allows us to generate particular E2~Ub conjugates and investigate their activity in cells without complications from competing Ub- transfer reactions. The new knowledge we seek to obtain will have a significant impact our understanding of human E2 structure and function and greatly accelerate biological research involving ubiquitylation and ubiquitin signaling.
通过泛素 (Ub) 信号传导的细胞内通讯影响真核细胞生物学的各个方面 调节对人类发展和生存至关重要的途径。 Ub 信号的畸变或缺陷可以 导致许多使人衰弱的疾病,包括神经退行性疾病、感染和癌症。尽管 几十年来取得了显着的进展,但我们对分子因素仍然只有初步的了解 以及控制调节 Ub 转移所需蛋白质组装的相互作用网络 发信号。干预与 Ub 信号转导相关的疾病的能力需要透彻了解 这些途径在分子水平上。 Ub修改的基本方案涉及协同活动 以及几种不同蛋白质的相互作用。该提案的重点是扩大我们对 泛素转移反应的核心参与者,这一类酶被称为泛素结合酶或 E2。一次 简单地认为 E2 可以将 Ub 运送到修饰位点,但新出现的证据表明 E2 可以发挥关键作用 在底物识别中的作用,确定靶蛋白 Ub 修饰的性质,甚至相互作用 与并影响传统 Ub 转移途径之外的蛋白质的活性。大约有 40 个 E2 人类基因组中的大多数被认为直接参与 Ub 转移。功能很少 大多数 E2 的信息均可用。本提案中概述的研究计划旨在 大大扩展了我们对E2功能的理解。使用各种生化方法、NMR 光谱学、晶体学和质谱学,该项目旨在开发一种分子 了解控制因素 1) E2~Ub 结合物对特定的内在活性 残基,2) E2~Ub 底物识别,以及 3) E2~Ub 缀合物的调节相互作用 调节主要 Ub 转移途径之外的蛋白质。我们已经适应并开发了新工具 用于识别被特定 E2~Ub 缀合物选择性修饰的蛋白质。我们利用新的“大肠杆菌” 可以在大肠杆菌中重建 Ub 转移途径的表达系统。该系统允许我们生成 特定的 E2~Ub 缀合物并研究它们在细胞中的活性,而不会因竞争 Ub-而出现并发症 转移反应。我们寻求获得的新知识将对我们的理解产生重大影响 人类 E2 结构和功能,大大加速涉及泛素化和 泛素信号传导。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER S BRZOVIC其他文献

PETER S BRZOVIC的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER S BRZOVIC', 18)}}的其他基金

Defining the role of BARD1 in nucleosomal ubiquitylation
定义 BARD1 在核小体泛素化中的作用
  • 批准号:
    10368107
  • 财政年份:
    2021
  • 资助金额:
    $ 28.25万
  • 项目类别:
Defining the role of BARD1 in nucleosomal ubiquitylation
定义 BARD1 在核小体泛素化中的作用
  • 批准号:
    10610818
  • 财政年份:
    2021
  • 资助金额:
    $ 28.25万
  • 项目类别:
Defining the role of BARD1 in nucleosomal ubiquitylation
定义 BARD1 在核小体泛素化中的作用
  • 批准号:
    10231875
  • 财政年份:
    2021
  • 资助金额:
    $ 28.25万
  • 项目类别:
Unconventional Interactions of Human Ubiquitin Conjugating Enzymes
人类泛素结合酶的非常规相互作用
  • 批准号:
    8528627
  • 财政年份:
    2012
  • 资助金额:
    $ 28.25万
  • 项目类别:
Unconventional Interactions of Human Ubiquitin Conjugating Enzymes
人类泛素结合酶的非常规相互作用
  • 批准号:
    8293759
  • 财政年份:
    2012
  • 资助金额:
    $ 28.25万
  • 项目类别:
Unconventional Interactions of Human Ubiquitin Conjugating Enzymes
人类泛素结合酶的非常规相互作用
  • 批准号:
    9276349
  • 财政年份:
    2012
  • 资助金额:
    $ 28.25万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 28.25万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.25万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 28.25万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.25万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 28.25万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.25万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 28.25万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 28.25万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 28.25万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.25万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了